134 related articles for article (PubMed ID: 37919620)
1. Neutrophil-to-lymphocyte ratio is an independent risk factor for proteinuria non-remission in idiopathic membranous nephropathy.
Zhuo N; Wang G; Wu G
Int Urol Nephrol; 2024 May; 56(5):1775-1776. PubMed ID: 37919620
[No Abstract] [Full Text] [Related]
2. Prognostic value of neutrophil-to-lymphocyte ratio on proteinuria remission in patients with idiopathic membranous nephropathy.
Gan W; Chen J; Zhu F; Fang X; Zeng X; Xiao W; Chen W
Int Urol Nephrol; 2024 Mar; 56(3):1185-1193. PubMed ID: 37733125
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression.
Hebert LA; Rovin BH; Agarwal AK; Spetie DN
Am J Kidney Dis; 2005 Apr; 45(4):788-9; author replyy 789-90. PubMed ID: 15806488
[No Abstract] [Full Text] [Related]
4. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.
Polanco N; Gutiérrez E; Covarsí A; Ariza F; Carreño A; Vigil A; Baltar J; Fernández-Fresnedo G; Martín C; Pons S; Lorenzo D; Bernis C; Arrizabalaga P; Fernández-Juárez G; Barrio V; Sierra M; Castellanos I; Espinosa M; Rivera F; Oliet A; Fernández-Vega F; Praga M;
J Am Soc Nephrol; 2010 Apr; 21(4):697-704. PubMed ID: 20110379
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus in resistant primary membranous nephropathy--a report of 3 cases.
Szeto CC; Leung CB; Lai FM; Li PK
Clin Nephrol; 2003 Apr; 59(4):293-6. PubMed ID: 12708570
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy.
Polenakovic M; Grcevska L; Dzikova S
Nephrol Dial Transplant; 2003 Jun; 18(6):1233-4. PubMed ID: 12748370
[No Abstract] [Full Text] [Related]
8. The ratio of neutrophils to lymphocytes effectively predicts clinical outcomes in idiopathic membranous nephropathy.
Zhao Q; Liu XQ; Jiang TT; Wang MY; Liu WT; Huang Y; Huang YL; Jin FY; Wu QY; Wang GH; Ruan XZ; Ma KL
Clin Nephrol; 2024 Mar; 101(3):101-108. PubMed ID: 38126194
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic Membranous Nephropathy and Treatment Related Complications.
Uncanin S; Dzemidzic J; Serdarevic N; Muslimovic A; Haskovic D
Med Arch; 2020 Jun; 74(3):228-232. PubMed ID: 32801441
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
Cheng YJ; Cheng XY; Zhang YM; Wang F; Wang X; Meng LQ; Liu G; Cui Z; Zhao MH
J Nephrol; 2022 May; 35(4):1145-1157. PubMed ID: 34846713
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab.
Dedinská I; Svetlík D; Adamicova K; Machalekova K; Makovicky P; Jezikova A; Laca L; Miklusica J; Galajda P; Mokan M
Iran J Kidney Dis; 2016 Sep; 10(5):332-335. PubMed ID: 27721233
[TBL] [Abstract][Full Text] [Related]
13. Coexisting Membranous Nephropathy and IgA Nephropathy.
Nishida M; Kato R; Hamaoka K
Fetal Pediatr Pathol; 2015; 34(6):351-4. PubMed ID: 26418809
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
[TBL] [Abstract][Full Text] [Related]
15. [Membranous glomerulonephritis].
Scheidat S; Stahl RA
Internist (Berl); 2003 Sep; 44(9):1120-30. PubMed ID: 14566465
[TBL] [Abstract][Full Text] [Related]
16. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
17. Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
Nishioka Y; Horita Y; Tadokoro M; Taura K; Suyama N; Miyazaki M; Harada T; Kohno S
Nephrol Dial Transplant; 2006 Aug; 21(8):2337-8. PubMed ID: 16547120
[No Abstract] [Full Text] [Related]
18. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
20. The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study.
Xie Z; Li Z; Dong W; Chen Y; Li R; Wu Y; Liang H; Ye Z; Liu S; Shi W; Liang X
BMC Nephrol; 2020 Jun; 21(1):224. PubMed ID: 32532223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
